from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1078/pra

LFCtreatmentdescriptionclass of inhibitor

0.822

Amikacinug/mL Amikacintranslation

0.726

Cap5-10ug/mL Capreomycintranslation

0.056

Rox10-50 ug/mL Roxithromycintranslation

0.694

SM2-5 ug/mL Streptomycintranslation

0.369

Tet5-10 ug/mL Tetracyclinetranslation

-0.911

Rif0.2-5ug/mL Rifampicintranscription

-0.612

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.080

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.434

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.850

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.192

Clofazimine10-13 ug/mL Clofaziminerespiration

0.630

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.888

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.624

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.137

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.631

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.192

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.514

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.103

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.243

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.137

KCN5-20 ug/mL Potassium cyaniderespiration

-0.050

NaN30.2-2 mM Sodium aziderespiration

0.736

Nigericin50 uM Nigericinrespiration

-1.642

TRC10-150 ug/mL Triclosanrespiration

-1.485

TRZ10-25 ug/mL Thioridazinerespiration

-1.956

Valinomycin0.5-10 uM Valinomycinrespiration

0.686

ZnSO42 mM ZnSO4respiration

-0.561

menadione6-10 ug/mL Menadionerespiration

0.076

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.023

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.445

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.582

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.082

NRP_1Non-replicating persistence stage 1dosRassociated

0.715

Amp0.2mg/mL AmpicillincellWall

0.749

Cephalexin20-100 ug/mL CephalexincellWall

0.852

Cerulenin0.32-5 ug/mL CerulenincellWall

0.289

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.448

EMB10-20 ug/mL EthambutolcellWall

0.648

Eta12-40 ug/mL EthionamidecellWall

0.889

INH0.2-0.4 ug/mL IsoniazidcellWall

0.336

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.840

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.207

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.404

BZA0.12 mg/mL BenzamidearomaticAmides

-0.156

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.069

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.236

H2O24 mM hydrogen peroxideDNAdamaging

-0.076

Levo10 ug/mL LevofloxacinDNAdamaging

0.779

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.087

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.486

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.638

UVUV-irradiationDNAdamaging

-0.692

ARP41-4 ug/mL Antitubercular compound ARP4?

1.052

Antimycin12.5-50 ug/mL Antimycin A?

0.919

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.021

PA_110-50 ug/mL Antitubercular compound PA-1?

0.905

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.566

PA8240.2-2 ug/mL PA-824?

-1.452

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.058

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.371

Verapamil50 uM Verapamil?

0.913

mercaptoethanol2 mM 2-Mercaptoethanol?

0.516

methoxatin10-20 ug/mL Methoxatin?